ORGO Organogenesis Holdings Inc.
$0.94▼ -5.82%
Healthcare
Other
Volume 698.3K
Avg Volume (10D) 1.02M
Key Metrics & Fundamentals
Market Cap
$120.36M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.93 - 7.08
% vs 50 MA
-34.69%
% vs 200 MA
-61.62%
RSI-14
22.3
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.23
Free Cash Flow
-$32.75M
Gross Rev
$42.81M
Gross Profit
$19.13M
EBITDA
-$46.78M
COGS
$23.67M
Operating Exp
$71.31M
Operating Income
-$52.18M
EBIT
-$52.18M
Pretax Income
-$50.88M
Net Income
-$96.27M
EPS (Diluted)
-0.77
Price & Volume History
Loading chart…
Recent News
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
GlobeNewswire · Oct 12, 2026 4:10 PM ET
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
GlobeNewswire · Oct 12, 2026 4:05 PM ET
Organogenesis (ORGO) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 7:46 PM ET
Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution
Simply Wall St. · Aug 10, 2026 1:10 AM ET
Organogenesis Holdings (ORGO) Is Down 21.5% After Slashing 2026 Guidance And Launching Equity Offering – Has The Bull Case Changed?
Simply Wall St. · Aug 8, 2026 4:12 AM ET
Organogenesis Holdings Inc. Q2 2026 Earnings Call Summary
Moby · Aug 7, 2026 8:30 AM ET
Organogenesis Q2 Earnings Call Highlights
MarketBeat · Aug 7, 2026 3:04 AM ET
Organogenesis: Q2 Earnings Snapshot
Associated Press · Aug 6, 2026 5:22 PM ET
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 6, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ORGO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.